Methylene Blue and G6PD Deficiency: An Absolute Contraindication You Must Screen For
G6PD deficiency turns methylene blue from a treatment into a hemolysis trigger. Learn the mechanism, who is at risk, and why screening is non-negotiable.
G6PD deficiency turns methylene blue from a treatment into a hemolysis trigger. Learn the mechanism, who is at risk, and why screening is non-negotiable.
Methylene blue carries serious drug interaction risks, including serotonin syndrome with SSRIs and absolute contraindication in G6PD deficiency. Full checklist
Methylene blue dosage depends on the goal: learn the low-dose nootropic range, FDA-approved clinical dosing, and the critical safety limits you must not cross.
Methylene blue is absolutely contraindicated in G6PD deficiency, pregnancy, and significant renal impairment. Learn the mechanisms and serious risks before cons